Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2016

Feb 1, 2016

5262_dirs_2016-02-01_38aa0a12-1ee9-463b-a009-41c74f2809c8.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6546N

GlaxoSmithKline PLC

01 February 2016

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons

In accordance with DTR 3.1.4R(1)(a) and (c) I give details of changes in the interests of the following Directors and Persons Discharging Managerial Responsibilities ('PDMR') who acquired Ordinary Shares ('Shares') in GlaxoSmithKline plc ('GSK') at a price of 1367.57 pence per Share, following the re-investment of the dividend paid to shareholders on 14 January 2016.

Director/PDMR Shares
Sir Andrew Witty 28.610
Mr S Dingemans 937.309
Mr S A Hussain 30.863
Mr D S Redfern 813.543
Dr M M Slaoui 164.460
Ms C Thomas 998.661
Mr P C Thomson 341.837
Dr P J T Vallance 1,210.723
Ms E Walmsley 939.015
Connected Person Shares
Mrs K Thomson (Connected Person to Mr P C Thomson) 110.075

GSK was informed of these allocations on 28 January 2016.

V A Whyte

Company Secretary

1 February 2016

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSXFLFBQLFBBBL